Exosomal Metabolic Signatures Are Associated with Differential Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

Neoadjuvant chemotherapy (NAC) is commonly used in breast cancer (BC) patients to increase eligibility for breast-conserving surgery. Only 30% of patients with BC show pathologic complete response (pCR) after NAC, and residual disease (RD) is associated with poor long-term prognosis. A critical barr...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Shriya, Garlapati, Chakravarthy, Bhattarai, Shristi, Su, Yixin, Rios-Colon, Leslimar, Deep, Gagan, Torres, Mylin A., Aneja, Ritu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141543/
https://www.ncbi.nlm.nih.gov/pubmed/35628139
http://dx.doi.org/10.3390/ijms23105324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141543/
https://www.ncbi.nlm.nih.gov/pubmed/35628139
http://dx.doi.org/10.3390/ijms23105324

Ejemplares similares